Memory B cells from RR-MS patients were shown to induce an increased response of CD4+ T cells to myelin antigens compared to memory B cells from healthy controls, also pointing toward a role of B cells as APCs (138). This evidence concerns the gene CD4 and myeloid sarcoma.